Our analytical framework applied to the ENABLE case
| ENABLE | Specific drug programs | |||
|---|---|---|---|---|
| 1. Temporality issues/time constraints | Private part: Actor: new programs (and their owners) joining, termination of programs, personnel turnover, exposure to new contacts Resource: lack of development programs, Drug Discovery Platform underused Activity: creation of routines by CMO/PMC for milestone declaration, go/no-go decisions, new hit-owners routines and fast time expectations on activities | Public part: Actor: new programs joining, termination of programs (Lower personnel turnover), exposure to new contacts Resource: changing resource constellation, bottlenecks, required timely and effective use of resources Activity: creation of routines by CMO/PMC for milestone declaration and go/no-go decisions, expectations of highest speed for drug discovery hub activities, allocation and re-allocation of resources depending on periodic volumes | Private part: Actor: development of trust, alignment of goals, stress for some Resource: pivotal effective use of resources, other funding running out fast (SMEs) Activity: take longer time than expected, pushing to get times respected by public partners, preparation for PMC meetings, need high coordination and follow ENABLE pacing | Public part: Actor: development of trust and commitment harder to achieve, alignment of goals, stress for most Resource: highly specialized resources, capacity constraints when time pressure, bottleneck for delivery of data Activity: new experiment procedures, short timelines, no time for writing publications and general learning |
| 2. Coordination tools for the time issues | Private part: Actor: meetings and specified roles Resource: PMC timeline request, budgets and periodic resource allocation to various partners Activity: milestones, indicative timelines for development stages and termination of entire project | Public part: Actor: meetings and specified roles Resource: PMC timeline request, budgets and periodic resource allocation to various partners Activity: milestones, indicative timelines for development stages and termination of the entire project | Private part: Actor: meetings and specified roles Resource: suggested timelines and strict criteria on molecule qualities for program progress Activity: flowcharts, timelines and termination decision of a program, role-based coordination | Public part: Actor: meetings and specified roles Resource: suggested timelines and strict criteria on molecule qualities for program progress Activity: flowcharts, timelines and termination decision of a program, roles-based coordination |
| 3. Consequences for the parties | Private part: Actor: turnover of personnel and of organizations require to rebuild trust constantly. New contacts Resource: fair possibility of reaching overall project goals in terms of molecules. New resource constellations Activity: highly coordinated routines, but possible delays when new partner enter and need to learn ENABLE process. New activity patterns | Public part: Actor: need to rebuilt trust with new private counterparts. New contacts Resource: bottlenecks during the project for all programs, funding will be stopped when ENABLE ends, and very limited academic publication output. New resource constellations Activity: learn how to perform new fast routines for efficient project management, no performance of academic research activities. New activity patterns | Private part: Actor: high turnover of personnel, relationships started outside ENABLE. New actor bonds Resource: longer (delayed) development time for key molecules, loss of competence for specific molecules. New resources ties Activity: coordination with public partners sometimes difficult due to different time-orientations. New activity links | Public part: Actor: some turnover of personnel and need to rebuild trust and commitment, relationships started outside ENABLE. New actor bonds Resource: loss of some competence, difficult recruitment, new technologies need new adaptions, adapted resources not transferrable to other programs. New resources ties Activity: some adaptions occurred, learnt new routines and how to work under time-pressure. New activity links |
| ENABLE | Specific drug programs | |||
|---|---|---|---|---|
| Private part: | Public part: | Private part: | Public part: | |
| Private part: | Public part: | Private part: | Public part: | |
| Private part: | Public part: | Private part: | Public part: | |
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.